NCT02211508 - Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 | Biotech Hunter

Enrollment

236

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Fibromyalgia

Interventions

DEVICE

RINCE

The NeuroPoint device is used to deliver repeat applications of RINCE therapy

Trial Locations (16)

10168

Fieve Clinical Research, New York

14221

Upstate Clinical Research Associates, Williamsville

32720

Avail Clinical Research, DeLand

32806

Compass Research LLC, Orlando

35216

Achieve Clinical Research, LLC, Birmingham

45219

University of Cincinnati College of Medicine, Cincinnati

48104

Michigan Head Pain & Neurological Institute, Ann Arbor

60634

Chicago Research Center, Chicago

84102

Fatigue Consultation Clinic, Salt Lake City

85027

Premier Research, Phoenix

92103

Artemis Institute for Clinical Research, San Diego

94558

Neurovations, Napa

95825

Superior Research LLC, Sacramento

97504

Sunstone Medical Research, Medford

98122

Swedish Clinical Research, Seattle

02886

Omega Medical Research, Warwick